News & Updates

Apolipoprotein markers linked to erectile dysfunction risk

19 May 2021

Alterations in the levels of apolipoprotein (Apo) A and B, as well as the ratio between the two molecules (Apo A/Apo B), seem to predict the risk of erectile dysfunction (ED), a recent study has found.

Apolipoprotein markers linked to erectile dysfunction risk

19 May 2021

Lumasiran shows therapeutic potential for primary hyperoxaluria type 1

17 May 2021 by

The RNAi* therapeutic agent lumasiran demonstrated favourable clinical outcomes for primary hyperoxaluria type 1 (PH1) in both paediatric and adult patients, according to the results of the phase III ILLUMINATE-A and ILLUMINATE-B trials presented at PAS 2021.

Lumasiran shows therapeutic potential for primary hyperoxaluria type 1

17 May 2021

Updated IMvigor130 data shows OS benefit of atezolizumab for bladder cancer

10 May 2021 by

Updated analyses of the phase III IMvigor130 trial presented at AACR 2021 revealed the overall survival (OS) benefit of atezolizumab for previously untreated locally advanced or metastatic urothelial carcinoma (mUC), be it alone or with platinum/gemcitabine chemotherapy (CT).

Updated IMvigor130 data shows OS benefit of atezolizumab for bladder cancer

10 May 2021

Men with higher-risk prostate cancer more likely to die from other causes

09 May 2021

Men with low-risk prostate cancer have better other-cause survival than those with higher-risk disease even after controlling for lifestyle characteristics and comorbidities, a study has shown.

Men with higher-risk prostate cancer more likely to die from other causes

09 May 2021

How accurate are self-reports of smoking exposure in bladder cancer?

08 May 2021

A recent study suggests the need for biochemical verification with cotinine or additional questions about other sources of nicotine to accurately identify nonmuscle invasive bladder cancer (NMIBC) patients who have smoking-related exposures.

How accurate are self-reports of smoking exposure in bladder cancer?

08 May 2021

Induced hypothermia does not preserve kidney function during partial nephrectomy

08 May 2021

While surgeons usually induce renal hypothermia during partial nephrectomy, recent evidence from a randomized controlled trial (RCT) suggests that such approach does not preserve kidney function in patients with normal or mildly impaired renal function.

Induced hypothermia does not preserve kidney function during partial nephrectomy

08 May 2021

Pro-inflammatory diets worsen urinary incontinence risk in women

08 May 2021

Adopting more pro-inflammatory diets can increase the risk of urinary incontinence among women younger than 65 years, a recent study has found.

Pro-inflammatory diets worsen urinary incontinence risk in women

08 May 2021

Healthy lifestyle could reduce lethal prostate cancer risk

07 May 2021 by

Having a healthy lifestyle could reduce the risk of lethal prostate cancer even in men with a high genetic risk for the disease, a recent study showed.

Healthy lifestyle could reduce lethal prostate cancer risk

07 May 2021

Automated performance metrics may predict outcomes during robotic partial nephrectomy

06 May 2021

A recent study has shown that expert surgeons are more efficient and focused in their movement during robot-assisted partial nephrectomy. In addition, automated performance metrics during key steps are associated with objective measures of tumour complexity and may predict clinical outcomes.

Automated performance metrics may predict outcomes during robotic partial nephrectomy

06 May 2021

Overactive bladder puts damper on hypertension management in men

05 May 2021

In the management of hypertension, men with overactive bladder are less likely to achieve blood pressure control than their peers who do not have the urological condition, according to a study.

Overactive bladder puts damper on hypertension management in men

05 May 2021

News & Updates

Filter by Specialty:

Specialty:

Apolipoprotein markers linked to erectile dysfunction risk

Apolipoprotein markers linked to erectile dysfunction risk

Lumasiran shows therapeutic potential for primary hyperoxaluria type 1

Lumasiran shows therapeutic potential for primary hyperoxaluria type 1

Updated IMvigor130 data shows OS benefit of atezolizumab for bladder cancer

Updated IMvigor130 data shows OS benefit of atezolizumab for bladder cancer

Men with higher-risk prostate cancer more likely to die from other causes

Men with higher-risk prostate cancer more likely to die from other causes

How accurate are self-reports of smoking exposure in bladder cancer?

How accurate are self-reports of smoking exposure in bladder cancer?

Induced hypothermia does not preserve kidney function during partial nephrectomy

Induced hypothermia does not preserve kidney function during partial nephrectomy

Pro-inflammatory diets worsen urinary incontinence risk in women

Pro-inflammatory diets worsen urinary incontinence risk in women

Healthy lifestyle could reduce lethal prostate cancer risk

Healthy lifestyle could reduce lethal prostate cancer risk

Automated performance metrics may predict outcomes during robotic partial nephrectomy

Automated performance metrics may predict outcomes during robotic partial nephrectomy

Overactive bladder puts damper on hypertension management in men

Overactive bladder puts damper on hypertension management in men